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Summary. Gastric cancer is one of the most frequent 
malignancies and its treatment is far from satisfactory. 
The challenge to oncologists is the characterization of 
novel chemical entities with greater effectiveness. 
Prodigiosin is a red pigment produced by various 
bacteria including Serrat ia rnarcescens. Here we 
characterize the apoptotic action of prodigiosin in human 
gastric carcinoma celi line (HGT-1). Cells were assayed 
by the MTT assay, fragmentation pattern of DNA, 
Hoechst 33342 staining and study of actin microfilament 
architecture. Treatment of these cells with prodigiosin 
showed a constant decrease in viability by apoptosis. 
Morphological analysis of prodigiosin-treated cells 
demonstrated that prodigiosin induces cell shrinkage, 
chromatin condensation, reorganization of actin 
microfilament architecture, and detachment of cells from 
the cell culture substrate. Altogether these results 
suggest that prodigiosin induces apoptosis in HGT-1 
human gastric cancer cells and raises the possibility of 
its use as a new chemotherapeutic drug. 
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lntroductlon 
Esophageal and gastric cancers pose a number of 
challenges for oncologists, gastroenterologists and 
surgeons. Surgical resection is  the most effective 
treatment in gastric cancer. Nevertheless, in the United 
States and Europe, curative resections are possible in 
only 50% to 60% of newly diagnosed gastric cancer 
patients (Kelsen, 1996). The current chemotherapy 
treatment for these patients is 5-fluorouracil (5-FU), 
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which alone or in combination with other drugs like 
cisplatin (Lokich, 1998; Ross et al., 1998), induces 
apoptosis in tumor celis (Inada et al., 1997). 
Apoptosis is characterized by internucleosomal 
DNA degradation, chromatin condensation and distinct 
histological features (Kerr et al., 1994). Unlike necrotic 
death, apoptosis is an active process involving the 
programmed activation of signaling cascades that are 
necessary to induce cell death. Apoptosis plays an 
important role in development and tissue homeostasis, 
and provides defense against vira1 infection and 
oncogenesis (Raff, 1992; Vaux et  al., 1994). The 
importance of apoptosis as an anti-cancer agent has been 
demonstrated in many tumor cell types in response to a 
broad range of drugs (Hannun, 1997; Cameron and 
Feuer, 2000). The identification of novel targets and 
development of new, more specific chemotherapeutic 
agents are two of the most important goals of research 
on cancer therapy. Severa1 bacteriai pathogens have been 
identified as mediators of apoptosis in vitro and during 
pathogenesis (Zychlinsky and Santonetti, 1997). 
Bacteriai toxins like leukotoxin, a-toxin and haemolysin 
form pores in the eukaryotic cell membrane and dismpt 
the cell via osmotic swelling (Hildebrand et al., 1991; 
Mangan et al., 1991; Jonas et al., 1993). Other toxins 
like diphtheria toxin and exotoxin A inhibit protein 
synthesis, causing apoptosis in eukaryotic cells 
(Morimoto and Bonavida, 1992; Kochi and Collier, 
1993). Verotoxin 1, the active component of the 
bacteriocin preparation from Escherichia coli, induces 
apoptosis in human cancer cell lines (Arab et d., 1998) 
and eliminates human astrocytoma xenografts (Arab et 
al., 1999). 
A family of natural red pigments called prodigiosins 
are svnthesized from different bacteria. ~c ío~rod ig ios in  
hydrÓchloride (cPrG.HC1) and undecylp~di$osin~(UP) 
are members of this family for which immuno- 
suppressive and apoptotic activities have been described 
(Kawauchi et al., 1997; Songia et al., 1997). Very 
recently, screening 2or anticancer agents in vim in our 
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laboratory led to the discovery that prodigiosin produced 
by Serratia marcescens 2170 triggered apoptosis in 
different cancer cell lines, behaving as a rapid, potent 
and selective drug (Montaner et al., 2000; Montaner and 
Pérez-Tomás, 2001). The fact that the antiproliferative 
effect of prodigiosin is p53-independent (Montaner et 
al., 2000) makes prodigiosin an interesting new 
antineoplasic candidate to study in cell culture cancer 
models. We decided to study the effect of prodigiosin in 
a human gastric cancer cell culture model for the 
following reasons: a) gastric cancer is the second cause 
of amual mortality worldwide, with over 600,000 deaths 
in 1990 (Pisani et al., 1999); b) gastric cancer cells have 
a low sensitivity to chemotherapy agents (Toge, 1999); 
and c) at present, chemotherapeutic choices are limited 
to 5-FU, and the benefits, in terms of tumor regression or 
improvement of symptoms, are limited. 
The purpose of this study was to analyze the effect 
of prodigiosin in the human gastric carcinoma ceii line 
(HGT-1). We quantified the loss of viability by M l T  
assay; we also stained DNA with Hoechst 33342 for 
morphological identification of apoptotic cells and we 
studied the ladder pattern of DNA after agarose gel 
electrophoresis, which is a biochemical feature of 
apoptotic cells. Finally, we examined whether 
prodigiosin affected the actin cytoskeleton during 
apoptosis, and whether such an effect was reversible. 
Materials and methods 
Chemical and reagents 
Meat peptone was purchased from Difco (Detroit, 
Michigan, USA). Glycerol was bought from Merck 
(Darmstadt, Germany). 3-(4,5-Dimethylthiazol-2-y1)- 
2,5-diphenyltetrazolium bromide (MTT) and Hoechst 
33342 were purchased from Sigma Chemicals Co (St 
Louis, MO, USA). Deionized water further purified with 
a Millipore Milli-Q system (Bedford, MA) was used. 
Cell lines and culture conditions 
HGT-1 (clone 6) human gastric carcinoma cell line 
was a generous gift from C.L. Laboisse (Laboisse et al., 
1982). Cells were cultured in DMEM, purchased from 
Biological Industries (Beit Haemek, Israel) and 
supplemented with 10% of heat-inactivated FBS, 100 
Ulml penicillin, 100 mgtrnl streptomycin, and 2mM L 
glutamine (al1 from GIBCO BRL, Paisley, UK), at 
37 "C, 5% C02 in air. 
Bacteria strain and culture conditions 
S. marcescens 2170 environmental isolate is a wild- 
type strain that produces the characteristic pigment 
prodigiosin. S. marcescens 2170 was inoculated into 25 
m1 of peptone glycerol (PG) medium, containing 1% 
meat peptone and 10% glycerol in distilled water, and 
cultivated for 8 h at 30 QC with v igoms shaking, and 1 
m1 was then transferred to 250 m1 of PG medium and 
cultivated for 48 h at 30 OC with vigorous shaking. 
Bacteria were then harvested by centrifugation at 6,800g 
for 15 minutes at 4 "C. Prodigiosin was extracted by 
shaking the pellet with acidic methanol (methano1:lN 
HCl (24:l)) and centrifuged at 2,000g for 5 minutes at 
room temperature. The supernatant was evaporated 
under vacuum and the pigment was re-dissolved in 
DMSO, divided into aliquots and stored at -20 QC. 
lsolation and purification of prodigiosin 
Prodigiosin was measured using the difference in 
absorption of the concentrated supernatant at 534 and 
655 nm. A difference in absorbency of 1.0 between the 
two wavelengths is equivalent to 19.3 p g  of prodigiosin 
per m1 (Goldschmidt and Williams, 1968). 
Furthermore, prodigiosin was purified as described 
previously (Montaner et al., 2000). Briefly, after 
evaporation under vacuum of the acidic methanol 
solvent, atmospheric pressure liquid chromatography of 
the extract was performed on silica gel with chloroform 
and methanol as solvents. The eluted fractions were 
pooled and the chloroform/methanol extract was vacuum 
evaporated, re-disolved in H20 and lyophilized. The 
isolated pigment was re-dissolved in methanol and 
analyzed by electrospray ionization mass spectrometry 
(ESI-MS) using a VG-Quattro triple mass spectrometer 
(Micromass. VG-Biotech, UK). The isolated pigment 
was re-purified by subsequent semi-preparative HPLC 
on a Shimadzu instrument (Kyoto, Japan). A Nucleosil 
C18 reversed-phase column (250x4 mm, 10 pm) was 
used with a 0% to 100% linear gradient in 30 minutes 
(A: 10 mM ammonium acetate, pH 7.0, B: 100 % 
acetonitrile). The elution was monitored by using both 
diode-array W detector (SPD-MlOAVP Shimadzu) and 
by ESI-MS. After repeated injections the pooled 
fractions containing the major peak were vacuum 
evaporated, re-dissolved in H20, lyophilized and 
characterized by ESI-MS and IH-NMR. ESI, rn/z 324.4 
C H N O requires 323.4381 (MW f 20 25 
average)). H-NMR (ED~oD, 500 MHz, ppm); 10.71 
(m, NH), 8.54 (m, NH), 7.08 (S, lH), 6.95 (S, lH), 6.88 
(m, lH), 6.83 (m, lH), 6.30 (m, lH), 6.25 (S, lH), 3.96 
(S, 3H), 2.43 (t, 2H), 1.58 (S, 3H), 1.2-1.4 (m, 6H), 0.91 
(t, 3H). 
Cell viabíliíy assay 
Cell viability was determined by the MTT assay 
(Mosmann, 1983). Briefly, 20x10~ cells were incubated 
in 96-well microtiter cell culture plates, in the absence 
(control cells) or in the presence of 0.5 to 4.0 p M  of 
prodigiosin in a final volume of 100 ml. After 4 h. 
incubation, 10 mM of MTT (diluted in PBS) was added 
to each well for an additional 4 h. The blue MTT 
formazan precipitate was dissolved in 100 p l  of 
isopropano1:lN HCl (24:l) and the absorbance at 550 
nm was measured on a multiwell plate reader. Cell 
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viability was expressed as a percentage of control. Data 
are shown as the mean valuekstandard Deviation of 
triplicate cultures. 
Analysis of DNA fragmentation 
Analysis of DNA fragmentation by agarose gel 
electrophoresis was performed as described previously 
(Montaner et al., 2000). Briefly, 1 x 1 0 ~  cells per 2 m1 
were exposed to &M of prodigiosin and incubated for 
12 h. Cells were washed in PBS and resuspended in ice- 
cold lysis buffer (10 mM Tris-HC1 pH 7.4,l mM EDTA, 
0.2% Triton X-100). After incubating for 15 minutes at 
4 "C, cell lysates were centrifuged at 14,000g for 15 min 
and the supernatants were treated with 0.2 mglml of 
proteinase K in a buffer containing 150 mM NaCl, 10 
mM Tris-HCl pH 8.0,40 mM EDTA and 1% SDS, for 4 
h at 37 "C. The DNA preparations were phenoll 
chloroform-extracted twice and DNA was precipitated 
with 140 mM NaCl and two volumes of ethanol at 
-20 "C overnight. DNA precipitates were recovered by 
centrifugation at 14,000g for 10 minutes at 4 "C, washed 
twice in cool 70% ethanol and air dried. DNA pellets 
were resupended in 15 m1 of TE (10 mM Tris-HCl pH 
8.0, 1 mM EDTA) and treated with DNase-free RNase 
(Boehringer Mannheim, Mannheim, Germany) for 1 h at 
37 "C. 3.2 y1 of 6X loading buffer was added to each 
tube and the DNA preparations were electrophoresed in 
1% agarose gels containing ethidium bromide. Gels were 
placed on a UV light box to visualize the DNA ladder 
pattern. 
Hoechsi staining 
Cell morphology was evaluated by fluorescence 
microscopy following Hoechst 33342 DNA staining. 
HGT-1 cells ( 4 x 1 0 ~  per ml) were incubated in the 
absence (control cells) or in the presence of 3 p M  of 
prodigiosin and incubated for 2 and 3 h. Cells were then 
washed in PBS and resuspended in PBS plus Hoechst 
33342 to a final concentration of 2 yglml and incubated 
for 30 minutes at 37 "C in the dark. After incubation, 
cells were washed in PBS and the sections were 
examined with a Leitz Diaplan microscope and 
photographed with a Wild MPS 45 Photoautomat 
system. Apoptotic cells were identified by nuclear 
condensation, formation of membrane blebs and 
apoptotic bodies. 
Analysis of actin microfilament organization 
HGT-1 cells were cultured to 70% confiuence over 
sterile coverslips introduced in plates. Cells were treated 
with 3 yM of prodigiosin and incubated for 1 , 2  and 3 h. 
respectively. 
Coverslips with treated and non-treated cells were 
washed in PBS and fixed for 1 h in Bouin solution at 
room temperature. After severa1 washes in PBS, cells 
were incubated for 5 min in 0.1% Triton X-100. The 
coverslips were incubated with normal sheep serum for 1 
h at room temperature and then for 2 h. with mouse 
monoclonal anti-actin (at a dilution of 1:400 in PBS- 
NaN3-BSA from purchased liquid antisera; clone C4, 
ICN Biomedicals, Inc. cat. # 69100). Coverslips were 
rinsed in PBS and incubated for 1 h in sheep IgG anti- 
mouse Ig conjugated with FITC (at a dilution of 1:100 in 
PBS) as secondary antibody (Boehringer Mannheim. 
Germany). Cells were examined with microscope and 
filter. 
lsolafion and purification of prodigiosin from S. 
marceccens 2 1 70 
Prodigiosin was purified from S. marcescens 2170 
by methanollHC1 extraction followed by silica gel 
chromatography and semipreparative reverse-phase 
Flg. 1. A Cell vlabilii in prodigiosin- 
treated celis. The data were obtained 
from the trmtment of HGT-1 cell line 
with 0.5 to 4.0 pM of prodigiosin for 4 
h. Cell viability was determined by 
the MlT assay and is expressed as a 
percentage with respect to control 
cells. The results are from the assay 
of three independent experiments-. 
B. lnduction of DNA fragmentation by 
prodigiosin. HGT-1 cells are 
untreated (-) or incubated (+) for 
12 h. with 2 pM of prodigiosin. HGT-1 
cells are treated with 1mM of 
staurosporine (Ssp) as a positive 
control. The fragmented DNA was 
extracted and analyred by agarose 
gel electrophoresis. 
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HPLC. ESI-MS gave a molecular mass of 323.4 Da, 
ril consistent with the expected value for prodigiosin 
e (C2f325N30). The structure of prodigiosin was further 
C, con irmed by high-field IH-NMR spectroscopy. We used 
E the pigment extracted with acidic methanol from S. 
marcescens 2170, re-dissolved in DMSO, as a source of 
apoptotic activity in the human gastric carcinoma cell 
line. 
Prodigiosin decreased the viability of gastric cancer cells 
HGT-1 cells were incubated for 4 h. with doses of 
prodigiosin ranging from 0.5 to 4.0 pM, and cell 
viability was then determined by the MTT assay. A 
significant dose-dependent decrease in the number of 
2 h. viable cells was observed, with an IC of 3.1 pM (Fig. 1A). The viability study of this ce l f~ ine  treated with 
prodigiosin at different times (4 to 24 h) did not show 
differences (data not shown). 
Prodigiosin induced apoptosis in gastric cancer cells 
In order to determine whether this cytotoxic effect 
was due to apoptosis, we analyzed whether prodigiosin 
induced DNA fragmentation. Agarose gel electro- 
phoresis of DNA showed the characteristic ladder 
pattern of apoptosis in HGT-1 cells incubated for 12 h in 3 h. the presence of 2 pM of prodigiosin (Fig. 1B). 
We corroborated these results at microscopic leve1 
using Hoechst 33342 staining. In contrast to untreated 
cells, the apoptotic nuclei of HGT-1 gave stronger blue 
fluorescence and were condensed, and occasionally we 
saw holes in the nuclei of dead cells (Fig. 2). These 
results demonstrate that prodigiosin induces changes in 
Flg. 2. Fluorescente microswpic analysis of HGT-1 nuclei with Hoechst morphology characteristic of apoptotic cell 33342 staining. Nuclear morphology of cells untreated (control) or 
treated with 3 pM of prodigiosin for 2 and 3 h. Apoptotic nuclei are death. 
condensed and smaller. x 200, x 200 and x 500, respectively. 
Control 1 h. 2 h. 3 h. 
Flg. 3. Morphology of cells untreated (control) or treated with 3 pM of prodigiosin for 1,2 and 3 h. A. Actin immunostaining of untreated cells (control) is 
0bSe~ed as an intense and d i s e  pattern evenly distributed within the cell (x 200). In treated cells the actin immunostaining is confined around the 
nucleus, and 3 h after treatment vesicles are obsewed within the cytoplasm showing intense actin immunostaining. x 160, x 160 and x 160, 
respectively. B. Confluent cells of untreated cells (control) show a morphological change after prodigiosin treatment; the cytoplasm has almost 
disappeared and the cells are smaller and rounded. After 3 h in culture, the cells have completely detached from plates and the plasma membrane is 
niffled. x 60, x 130, x 130 and x 130 respectively). 
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Effect of prodigiosin on the organization of actin 
microfilaments 
HGT-1 cells grew as monolayers of closely apposed 
polygonal cells with epithelial morphology. Most cells 
were mononuclear, but bi- and multinucleated cells were 
also observed. 
Actin immunostaining showed a typical fiber 
network. Actin microfilaments were seen in a parallel 
pattern depending on the plane of focus and more 
concentrated around the nucleus (Fig. 3). Sometimes, 
punctuate structures of non-filamentous actin were seen 
in the extensions of lamellipodia. Immunostaining 
appeared more intense at the point of contact between 
cells. 
Treatment with 2 pM of prodigiosin caused 
progressive morphological changes. Within the first 
hour, cells which had previously been almost completely 
confluent, had retracted and the plasma membrane 
started to ruffle (Fig. 3). By the second hour of treatment 
confluent cells had also begun to shrink, the cytoplasm 
almost disappeared and became rounded. In about 3 h, 
cells dettached from plates and typical apoptotic bodies 
were seen at the boundaries of detached cells (Fig. 3). 
Vesicles observed within the cytoplasm of treated 
cells were densely stained with anti-actin antibodies. 
Aoo~totic bodies of rounded detached cells were stained 
($ig: 3). 
We also saw many rounded cells with ray-like 
immunostaining, indicating the formation of numerous 
filopodia or perhaps microvilli (data not shown). 
Retraction of the cytoplasm was accompanied by 
condensation of the immunostaining around the nucleus 
of these cells, which may have come from non-confluent 
regions of plates. When the cells were exposed to 
prodigiosin for 2 h, washed in PBS and treated with the 
culture medium without prodigiosin, they began to grow 
and attach to the substratum (data not shown). These 
results demonstrate that the effect of prodigiosin on 
HGT-1 cells was reversible. 
These results indicate that cells treated with 
prodigiosin detached from the substratum. This induced 
the reorganization of actin microfilament architecture, 
and cells died by apoptosis. 
Discussion 
We have recently reported the apoptotic effect of 
prodigiosin synthesized by S. marcescens 2170 on 
severa1 human cancer cell lines like Jurkat, NSO, HG60, 
Ramos (al1 of hematopoietic origin), SW-620, and DLD- 
1 (human colon origin), but not in non-malignant cells 
like NIH-3T3, Swiss-3T3 and MDCK (Montaner et al., 
2001). Here we extend our study of prodigiosin-induced 
apoptosis to the human gastric carcinoma cell line 
(HGT-1) and we examine the possibility that actin 
microfilaments could be a target of this molecule. 
The prevention of neoplasia by agents of bacteria1 
origin that inhibit cancer cell proliferation and with no 
appreciable toxicity for normal cells is an attractive 
prospect. In this connection, a family of natural red 
pigments called prodigiosins, which are synthesized 
from bacteria, have been described. Cycloprodigiosin 
hydrochloride (cPrG.HC1) and Prodigiosin 25-C (UP) 
are reported to have immunosuppressive and apoptotic 
effects (Kawauchi et al., 1997; Songia et al., 1997). For a 
third member, prodigiosin, Han et al. (1998) described T- 
cell-specific immunosuppression but no data were 
reported on the involvement of prodigiosin in apoptotic 
cell death in human gastric carcinoma. Here we 
demonstrate that apoptotic cell death is induced in the 
human gastric carcinoma cell line HGT-1. Analysis of 
actin cytoskeleton in HGT-1 with FITC-conjugated actin 
revealed that actin filaments of cells that were not 
treated with prodigiosin were organized into a dense, 
dynamic meshwork of actin fibers, whereas the actin 
fibers of prodigiosin-treated cells were either 
disorganized, disassembled, or disrupted. These 
observations suggest that prodigiosin promotes the 
breakdown of actin microfilament, and this is the first 
demonstration that prodigiosin causes the reorganization 
of actin cytoskeleton. Arguably, it may be difficult to 
assess whether cleavage of a particular protein substrate 
is part of the endogenous cell death program, or an 
unrelated consequence of the lethal stimulus. However, 
Levee et al. (1996) suggest that reorganization of the 
microfilament network is necessary for the formation of 
apoptotic bodies, and depolymerization of F-actin may 
also be necessary for apoptosis. 
Mgbonyebi et al. (1999) suggest that cdk inhibitors 
like roscovitine may be involved in cytoskeletal 
regulation, by reducing the polymerization of actin 
microfilaments. We have demonstrated that prodigiosin 
causes the reorganization of actin cytoskeleton and may 
promote the breakdown of actin microfilaments. These 
findings combined with our previous observations of 
inhibition of cdk2 activity in prodigiosin-treated cells 
(unpublished data) indicate that prodigiosin follows the 
same mechanism as roscovitine. 
During the past few years, new compounds like 
cytochalasins, lantrunculins, jasplakinolide, swinholide 
A and inhibitors or farnesyltransferase (Cooper, 1987; 
Bubb et al., 1995; Senderowicz et al., 1995; Ayscough et 
al., 1997; Gibbs and O l a ,  1997), al1 of natural origin, 
have been found to modulate actin polymerization and 
dynamics, often by unique mechanisms (Jordan and 
Wilson, 1998). These molecules, together with 
prodigiosin, are likely to become valuable tools for the 
analysis of actin dynamics and functions in cells. 
Because they inhibit cell proliferation, they or their 
derivatives have potential as chemotherapeutic agents in 
the treatment of cancer. 
Interestingly, prodigiosin induces apoptosis in Jurkat 
and HL-60 cells, both of which are p53-deficient 
(Montaner et al., 2000). Bcl-2 is an important gene 
product in the regulation of programmed cell death, 
acting as a suppressor (Korsmeyer, 1999). However, 
prodigiosin induced apoptosis in a Jurkat cell line stable 
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transfected with Bcl-2 with the same efficiency as in 
Jurkat cells with normal Bcl-2 expression (unpublished 
data). Oncogenesis is often associated with defects in 
p53 or with high expression of antiapoptotic genes, such 
as Bcl-2 family members. As prodigiosin-induced 
apoptosis is p53-independent and it is not protected by 
Bcl-2, this could give it an advantage over other 
chemotherapeutic drugs (Bunz et al., 1999). 
The elucidation of the mechanisms involved in the 
apoptotic action of prodigiosin and its evaluation as a 
possible anticancer drug warrants further investigation. 
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